Other News Releases in Biotechnology
ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries
Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category
American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor
Other News Releases in Surveys, Polls and Research
ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries
Financial Facts Reports on Widespread Consumer Mistrust as Credit Card Transactions Drop 27%
U.S. Census Bureau Daily Feature for Nov. 21
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
See more news releases in: Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Education, Surveys, Polls and Research, Domestic Policy
Discovery Institute Bioethicist Lauds Breakthrough in Stem Cells Research that Eliminates Need for Human Cloning
SEATTLE, Nov. 20 /PRNewswire-USNewswire/ -- Scientists have announced
that they successfully reprogrammed adult cells back to an embryonic-like
state, opening the possibility of patient-specific medical treatments and
research without the need to clone human life.
Wesley J. Smith, the Discovery Institute's Senior Fellow in Bioethics
and author of Consumer's Guide to a Brave New World, hailed the
breakthrough as demonstrating that ethical science is also good science:
"Everyone should applaud this tremendous scientific achievement. We now
have the very real potential of developing thriving and robust stem cell
medicine and scientific research sectors that will bridge, rather than
exacerbate, our moral differences over the importance and meaning of human
life."
"This breakthrough demonstrates the creativity and intelligence of the
science sector," Smith added. "I think President Bush deserves some credit
for the exciting research into 'alternative methods' of deriving
pluripotent cells. Had the president followed the crowd instead of leading
it, most research efforts would have been devoted to trying to perfect
embryonic stem cell and human cloning research-which despite copious
funding have not worked out yet as scientists originally had hoped."
Smith called upon the NIH, state, and private research funders to shift
their focus away from human cloning research and into the more viable
alternatives.
"We should now move to outlaw all human cloning," Smith explained. "It
is not only unethical to treat human life like an item of manufacture, but
it will divert billions of dollars and many years of our best researchers'
efforts way from areas of advancement that have the chance to do tremendous
good without the terrible moral cost of permitting human cloning."
SOURCE Discovery Institute













